These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 9203626)

  • 1. A new linear V1A vasopressin antagonist and its use in characterizing receptor/G protein interactions.
    Strakova Z; Kumar A; Watson AJ; Soloff MS
    Mol Pharmacol; 1997 Feb; 51(2):217-24. PubMed ID: 9203626
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A new series of photoactivatable and iodinatable linear vasopressin antagonists.
    Carnazzi E; Aumelas A; Barberis C; Guillon G; Seyer R
    J Med Chem; 1994 Jun; 37(12):1841-9. PubMed ID: 8021923
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coupling of oxytocin receptor to G proteins in rat myometrium during labor: Gi receptor interaction.
    Strakova Z; Soloff MS
    Am J Physiol; 1997 May; 272(5 Pt 1):E870-6. PubMed ID: 9176188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficient photoaffinity labeling of the rat V1a vasopressin receptor using a linear azidopeptidic antagonist.
    Carnazzi E; Aumelas A; Phalipou S; Mouillac B; Guillon G; Barberis C; Seyer R
    Eur J Biochem; 1997 Aug; 247(3):906-13. PubMed ID: 9288914
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The vasopressin-induced excitation of hypoglossal and facial motoneurons in young rats is mediated by V1a but not V1b receptors, and is independent of intracellular calcium signalling.
    Reymond-Marron I; Tribollet E; Raggenbass M
    Eur J Neurosci; 2006 Sep; 24(6):1565-74. PubMed ID: 17004920
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Probing the V1a vasopressin receptor binding site with pyroglutamate-substituted linear antagonists.
    Howl J; Yarwood NJ; Stock D; Wheatley M
    Neuropeptides; 1996 Feb; 30(1):73-9. PubMed ID: 8868303
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Solubilization of rat liver vasopressin receptors as a complex with a guanine-nucleotide-binding protein and phosphoinositide-specific phospholipase C.
    Aiyar N; Bennett CF; Nambi P; Valinski W; Angioli M; Minnich M; Crooke ST
    Biochem J; 1989 Jul; 261(1):63-70. PubMed ID: 2549966
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of vasopressin-mastoparan chimeric peptides on insulin release and G-protein activity.
    Hällbrink M; Saar K; Ostenson CG; Soomets U; Efendic S; Howl J; Wheatley M; Zorko M; Langel U
    Regul Pept; 1999 Jun; 82(1-3):45-51. PubMed ID: 10458645
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An exploration of the effects of L- and D-tetrahydroisoquinoline-3-carboxylic acid substitutions at positions 2, 3 and 7 in cyclic and linear antagonists of vasopressin and oxytocin and at position 3 in arginine vasopressin.
    Manning M; Cheng LL; Stoev S; Bankowski K; Przybyiski J; Klis WA; Sawyer WH; Wo NC; Chan WY
    J Pept Sci; 1995; 1(1):66-79. PubMed ID: 9222985
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Visualization of cell surface vasopressin V1a receptors in rat hepatocytes with a fluorescent linear antagonist.
    Tran D; Durroux T; Stelly N; Seyer R; Tordjmann T; Combettes L; Claret M
    J Histochem Cytochem; 1999 Mar; 47(3):401-10. PubMed ID: 10026242
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vasopressin-induced calcium signaling in cultured cortical neurons.
    Son MC; Brinton RD
    Brain Res; 1998 May; 793(1-2):244-54. PubMed ID: 9630655
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A radioiodinated linear vasopressin antagonist: a ligand with high affinity and specificity for V1a receptors.
    Schmidt A; Audigier S; Barberis C; Jard S; Manning M; Kolodziejczyk AS; Sawyer WH
    FEBS Lett; 1991 Apr; 282(1):77-81. PubMed ID: 1827414
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reconstitution of the rat liver vasopressin receptor coupled to guanine nucleotide-binding proteins.
    Dickey BF; Fishman JB; Fine RE; Navarro J
    J Biol Chem; 1987 Jun; 262(18):8738-42. PubMed ID: 2954955
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthetic rat V1a vasopressin receptor fragments interfere with vasopressin binding via specific interaction with the receptor.
    Mendre C; Dufour MN; Le Roux S; Seyer R; Guillou L; Calas B; Guillon G
    J Biol Chem; 1997 Aug; 272(34):21027-36. PubMed ID: 9261104
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Binding of [3H] SR 49059, a potent nonpeptide vasopressin V1a antagonist, to rat and human liver membranes.
    Serradeil-Le Gal C; Raufaste D; Marty E; Garcia C; Maffrand JP; Le Fur G
    Biochem Biophys Res Commun; 1994 Feb; 199(1):353-60. PubMed ID: 8123034
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatic vasopressin receptor: differential effects of divalent cations, guanine nucleotides, and N-ethylmaleimide on agonist and antagonist interactions with the V1 subtype receptor.
    Gopalakrishnan V; McNeill JR; Sulakhe PV; Triggle CR
    Endocrinology; 1988 Aug; 123(2):922-31. PubMed ID: 2969327
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of SR-49059, a vasopressin V1a antagonist, on human vascular smooth muscle cells.
    Serradeil-Le Gal C; Herbert JM; Delisee C; Schaeffer P; Raufaste D; Garcia C; Dol F; Marty E; Maffrand JP; Le Fur G
    Am J Physiol; 1995 Jan; 268(1 Pt 2):H404-10. PubMed ID: 7840290
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High concentrations of oxytocin cause vasoconstriction by activating vasopressin V1A receptors in the isolated perfused rat kidney.
    Loichot C; Krieger JP; De Jong W; Nisato D; Imbs JL; Barthelmebs M
    Naunyn Schmiedebergs Arch Pharmacol; 2001 Apr; 363(4):369-75. PubMed ID: 11330329
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological characterization of V1a vasopressin receptors in the rat cortical collecting duct.
    Ammar A; Roseau S; Butlen D
    Am J Physiol; 1992 Apr; 262(4 Pt 2):F546-53. PubMed ID: 1533099
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of the V1a antagonist, JNJ-17308616, in rodent models of anxiety-like behavior.
    Bleickardt CJ; Mullins DE; Macsweeney CP; Werner BJ; Pond AJ; Guzzi MF; Martin FD; Varty GB; Hodgson RA
    Psychopharmacology (Berl); 2009 Mar; 202(4):711-8. PubMed ID: 18923820
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.